{
  "main_header": {
    "sid": 604869,
    "name": "Marksans Pharma",
    "stock_name": "Marksans Pharma",
    "full_name": "Marksans Pharma Ltd",
    "name_url": "stocks-analysis/marksans-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "309.25",
    "chg": 1.35,
    "chgp": "0.44%",
    "dir": 1,
    "prev_price": "307.90",
    "mcapval": "14,073.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524404,
    "symbol": "MARKSANS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE750C01026",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "12.55 lacs",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/marksans-pharma-604869-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [],
    "total": 15,
    "sid": "604869",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/marksans-pharma-604869"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Sep-2026",
      "details": "Intimation of Closure of Trading Window for the quarter and half year ended 30 September 2026",
      "source": "BSE"
    },
    {
      "caption": "Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares",
      "datetime": "17-Sep-2026",
      "details": "Notice to Shareholders regarding re-opening of Special Window for Re-lodgement of transfer requests of Physical Shares",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-Sep-2026",
      "details": "Copy of Newspaper Publication regarding transfer of unclaimed dividend and equity shares of the Company to the IEPF",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Marksans Pharma Ltd has declared <strong>90%</strong> dividend, ex-date: 20 Aug 26",
          "dt": "2026-08-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Marksans Pharma Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Mar 08",
          "dt": "2008-03-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News